David Schaffer, Director at 4D Molecular Therapeutics Inc. (FDMT), sold 66,288 shares at $32.59 ($2.1M) on 2021-09-27, disclosed to the SEC on 2021-09-29.
Open-market sale of $2.1M FDMT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.59 | 13,075 | $426K | 20.2% |
| 2 | $32.59 | 13,075 | $426K | 20.2% |
| 3 | $33.51 | 6,157 | $206K | 9.8% |
| 4 | $33.51 | 6,157 | $206K | 9.8% |
| 5 | $34.19 | 100 | $3K | 0.2% |
| 6 | $30.52 | 13,812 |
| $422K |
| 19.9% |
| 7 | $30.52 | 13,812 | $422K | 19.9% |
| 8 | $32.00 | 100 | $3K | 0.2% |
| Total | $31.90 avg | 66,288 | $2.1M | 100% |
| Filing → |
| QURE | SELL | 2020-01-30 | $100K | — | Filing → |
| QURE | SELL | 2019-01-30 | $38K | — | Filing → |
| QURE | SELL | 2019-01-29 | $230K | — | Filing → |